Edition:
United States

Medtronic PLC (MDT.N)

MDT.N on New York Stock Exchange

79.90USD
20 Apr 2018
Change (% chg)

$-0.10 (-0.12%)
Prev Close
$80.00
Open
$80.10
Day's High
$80.49
Day's Low
$79.48
Volume
1,437,585
Avg. Vol
1,343,373
52-wk High
$89.71
52-wk Low
$76.42

Select another date:

Tue, Apr 17 2018

BRIEF-Medtronic Announces U.S. Launch Of Optisphere Embolization Spheres

* MEDTRONIC - ANNOUNCES U.S. LAUNCH OF OPTISPHERE EMBOLIZATION SPHERES, A RESORBABLE EMBOLIC PLATFORM DESIGNED FOR EMBOLIZATION OF HYPERVASCULAR TUMORS Source text for Eikon: Further company coverage:

BRIEF-Medtronic Expands Visualase MRI-Guided Laser Ablation System to Europe with CE Mark Approval

* MEDTRONIC EXPANDS VISUALASE(TM) MRI-GUIDED LASER ABLATION SYSTEM TO EUROPEAN MARKETS WITH CE MARK APPROVAL

BRIEF-UK's CMA Says Investigating Completed Acquisition By Medtronic Of Certain Assets Of Animas Corp

* CMA IS INVESTIGATING THE COMPLETED ACQUISITION BY MEDTRONIC PLC OF CERTAIN ASSETS OF ANIMAS CORPORATION Source text (http://bit.ly/2Ham0WD) Further company coverage:

BRIEF-Medtronic To Redeem About $1.2 Bln Of Medtronic Inc's Senior Notes

* MEDTRONIC PLC - INTENDS TO REDEEM ABOUT $1.2 BILLION OF MEDTRONIC, INC.'S SENIOR NOTES - SEC FILING

BRIEF-New Analyses Confirm Patients With Medtronic CRT Devices Experience Less Atrial Fibrillation, Are More Active

* NEW ANALYSES CONFIRM PATIENTS WITH MEDTRONIC CRT DEVICES EXPERIENCE LESS ATRIAL FIBRILLATION, ARE MORE ACTIVE Source text for Eikon: Further company coverage:

BRIEF-Medtronic Announces 1-Year Results From Cryo4persistent AF Study Of Ablation With Arctic Front Advance Cryoballoon

* MEDTRONIC - ANNOUNCED 1-YEAR RESULTS FROM CRYO4PERSISTENT AF STUDY OF ABLATION WITH ARCTIC FRONT ADVANCE CRYOBALLOON

BRIEF-Medtronic Gets FDA Approval For Guardian Connect CGM System For People With Diabetes

* MEDTRONIC RECEIVES FDA APPROVAL FOR GUARDIAN CONNECT CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM FOR PEOPLE LIVING WITH DIABETES

BRIEF-Medtronic PLC Says ‍Approved Fiscal Year 2018 Q4 Cash Dividend Of $0.46/Ordinary Share

* MEDTRONIC PLC - ‍APPROVED FISCAL YEAR 2018 Q4 CASH DIVIDEND OF $0.46/ORDINARY SHARE, REPRESENTING 7% INCREASE OVER PRIOR YEAR​ Source text for Eikon: Further company coverage:

BRIEF-Medtronic, Lehigh Valley Health Network To Deliver Healthcare Programs For LVHN Patients

* MEDTRONIC AND LEHIGH VALLEY HEALTH NETWORK SIGN STRATEGIC PARTNERSHIP AGREEMENT FOCUSED ON DELIVERING VALUE-BASED HEALTHCARE PROGRAMS

BRIEF-U.S. FDA Says Medtronic Recalls Certain Types Of Defibrillators

* U.S. FDA SAYS MEDTRONIC RECALLS CARDIAC RESYNCHRONIZATION THERAPY AND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS DUE TO MANUFACTURING ERROR

Select another date: